Skip to content

Clinical trials

Withdrawn Phase 3 Nervous System Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Nervous System Diseases Phase: Phase 3 Status: Withdrawn Clear all

3 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20101

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Flowonix Medical1
Hospira, now a wholly owned subsidiary of Pfizer1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Nervous System Diseases3
Brain Injuries1
Cerebral Palsy1
Congenital Abnormalities1
Congenital, Hereditary, and Neonatal Diseases and Abnormalities1
Delirium1
Multiple Sclerosis1
Muscle Spasticity1
Nervous System Malformations1
Neural Tube Defects1

Trials

Showing 1 to 3 of 3. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.